Back to startpage
Startpage / About psoriasis / Treatment / Treatment - Psoriatic Arthritis

Treatment - Psoriatic arthritis

Drugs for the treatment of psoriatic arthritis can be divided into several categories: nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs) and biologics, which are also considered DMARDs. A number of alternative and complementary approaches are also used in the treatment of psoriatic arthritis.  

The following treatments are not listed in any order of importance. Each case must be evaluated individually.

Aspirin and NSAIDs
Nonsteroidal anti-inflammatory drugs (NSAIDs), including over-the-counter medications such as aspirin and ibuprofen as well as prescription products, help to decrease inflammation, joint pain and stiffness.

DMARDs and biologics
Disease-modifying antirheumatic drugs (DMARDs) may relieve more severe symptoms and attempt to slow or stop joint and tissue damage and progression of psoriatic arthritis.

Biologics, such as Enbrel, Humira and Remicade, are also considered DMARDs. They are highly selective agents that target specific internal events in the body that cause psoriasis and psoriatic arthritis.

World of Psoriasis is presented by IFPA

Sponsors 2007

Merck Serono
Merck Serono are the founding sponsors of World Psoriasis Day


Argentina Argentina
Australia Australia
Belgium Belgium
Canada Canada
China China
Denmark Denmark
Estonia Estonia
Finland Finland
France France
Germany Germany
Iceland Iceland
Indonesia Indonesia
Japan Japan
Kenya Kenya
Malta Malta
Netherlands Netherlands
New Zealand New Zealand
Norway Norway
Philippines Philippines
Singapore Singapore
South Africa South Africa
Spain Spain
Sweden Sweden
Switzerland Switzerland
Tanzania Tanzania
United Kingdom United Kingdom

Copyright IFPA, International Federation of Psoriasis Associations